Korean Heart Failure Registry III
Recruiting · NCT04329234 · Observational (researchers observe without assigning treatment) · Lead sponsor: Seoul National University Bundang Hospital
View the official record on ClinicalTrials.gov →What this trial is about
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Symptoms of heart failure
- Signs of heart failure
- Lung congestion in Chest-x-ray
- Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels
Exclusion criteria
- Patients younger than 18 years old
- Patients who do no consent
Where it is running
1 location listed.
- Seoul National University Bundang Hospital - Seongnam, South Korea